Careers  |  Sign In  |  Register

Latest in Comprehensive Cancer Collection

Reuters Health • The Doctor's Channel Daily Newscast

Dactinomycin tops methotrexate for gestational trophoblastic neoplasia

NEW YORK (Reuters Health) - For women with low-risk gestational trophoblastic neoplasia, dactinomycin given every 2 weeks had a higher complete response rate than weekly methotrexate in a multinational, phase III trial. Despite these findings, editorialist Dr. Carol Aghajanian believes that most physicians...

Reuters Health • The Doctor's Channel Daily Newscast

Denosumab effective for breast cancer-related bone metastases

NEW YORK (Reuters Health) - Compared with zoledronic acid, the monoclonal antibody denosumab is more effective in delaying skeletal-related events in women with breast cancer that has metastasized to bone, according to the results of a new study. The finding is reported in the November 8 online issue of...

Reuters Health • The Doctor's Channel Daily Newscast

Gefitinib, erlotinib may slow CNS metastases in advanced lung cancer

NEW YORK (Reuters Health) - The tyrosine kinase inhibitors gefitinib or erlotinib may slow the development of central nervous system metastases in patients with advanced non-small cell lung cancer (NSCLC), if they carry sensitizing EGFR mutations. Those findings come from a Boston-based team, reporting in...